Gurrola Sandra M 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Exercise/Conversion
Common Stock
2022-06-21+8,750→ 16,953 total - Tax Payment
Common Stock
2022-06-21$0.48/sh−3,586$1,709→ 13,367 total - Exercise/Conversion
Restricted Stock Units
2022-06-21−8,750→ 26,250 total→ Common Stock (8,750 underlying)
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 21, 2021, the reporting person was granted 35,000 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.